Appili Therapeutics Inc. (TSX:APLI)
Canada · Delayed Price · Currency is CAD 0.0200
-0.0050 (-20.00%)
At close: Feb 9, 2026
Appili Therapeutics Employees
Appili Therapeutics had 7 employees as of March 31, 2025. The number of employees did not change compared to the previous year.
Employees
7
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
28.53K CAD
Profits / Employee
-362.13K CAD
Market Cap
2.57M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Mar 31, 2025 | 7 | 0 | - | 7 | 0 |
| Mar 31, 2024 | 7 | -2 | -22.22% | 7 | 0 |
| Mar 31, 2023 | 9 | 1 | 12.50% | 8 | 1 |
| Mar 31, 2022 | 8 | -8 | -50.00% | 8 | 0 |
| Mar 31, 2021 | 16 | - | - | 14 | 2 |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Appili Therapeutics News
- 3 months ago - Appili Therapeutics Inc. GAAP EPS of -$0.01 - Seeking Alpha
- 3 months ago - Appili Therapeutics Q2 Sales Increase - Nasdaq
- 3 months ago - Appili Therapeutics Reports Financial and Operational Results for Second Quarter of Fiscal Year 2026 - GlobeNewsWire
- 3 months ago - Appili Therapeutics to Attend BARDA Innovation Symposium 2025 - GlobeNewsWire
- 4 months ago - Appili Therapeutics and its Partner Vitalex Biosciences Awarded Contract from NIAID Valued at up to US$40 Million to Develop Fungal Vaccine VXV-01 - GlobeNewsWire
- 4 months ago - Appili Therapeutics Announces Results of Annual and Special Meeting of Shareholders - GlobeNewsWire
- 5 months ago - Appili Therapeutics to Present Progress on Tularemia Biodefense Vaccine at NATO CBRN Conference - GlobeNewsWire
- 6 months ago - Appili Therapeutics GAAP EPS of -$0.01 - Seeking Alpha